These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6983890)

  • 1. Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1.
    Krangel MS; Taketani S; Biddison WE; Strong DM; Strominger JL
    Biochemistry; 1982 Nov; 21(24):6313-21. PubMed ID: 6983890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region.
    Krangel MS; Biddison WE; Strominger JL
    J Immunol; 1983 Apr; 130(4):1856-62. PubMed ID: 6601143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
    van Schravendijk MR; Biddison WE; Berger AE; Coligan JE
    J Immunol; 1985 Jan; 134(1):410-6. PubMed ID: 3871112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.
    Biddison WE; Krangel MS; Strominger JL; Ward FE; Shearer GM; Shaw S
    Hum Immunol; 1980 Oct; 1(3):225-32. PubMed ID: 6167549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of HLA-A28*, a novel HLA product, and its relationship to HLA-A28 and HLA-A2.
    Holmes N; Parham P
    Immunogenetics; 1984; 20(2):103-15. PubMed ID: 6332065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HLA-A2 population variant with structural polymorphism in the alpha 3 region.
    Castaño R; Ezquerra A; Doménech N; López de Castro JA
    Immunogenetics; 1988; 27(5):345-55. PubMed ID: 3258580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.
    Russo C; Ng AK; Pellegrino MA; Ferrone S
    Immunogenetics; 1983; 18(1):23-35. PubMed ID: 6190744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants.
    Goulmy E; van Leeuwen A; Blokland E; van Rood JJ; Biddison WE
    J Exp Med; 1982 May; 155(5):1567-72. PubMed ID: 6175722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes.
    Doménech N; Ezquerra A; Castaño R; López de Castro JA
    Immunogenetics; 1988; 27(3):196-202. PubMed ID: 2448239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule.
    Salter RD; Clayberger C; Lomen CE; Krensky AM; Parham P
    J Exp Med; 1987 Jul; 166(1):283-8. PubMed ID: 2439636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes.
    Taketani S; Krangel MS; Spits H; de Vries J; Strominger JL
    J Immunol; 1984 Aug; 133(2):816-21. PubMed ID: 6429245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenogeneic cytotoxic T-cell clones recognize alloantigenic determinants on HLA-A2.
    Engelhard VH; Benjamin C
    Immunogenetics; 1983; 18(5):461-73. PubMed ID: 6196283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.
    Ezquerra A; Doménech N; van der Poel J; Strominger JL; Vega MA; López de Castro JA
    J Immunol; 1986 Sep; 137(5):1642-9. PubMed ID: 3489037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes.
    Vega MA; Wallace L; Rojo S; Bragado R; Aparicio P; López de Castro JA
    J Immunol; 1985 Nov; 135(5):3323-32. PubMed ID: 3930603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer.
    Herman A; Parham P; Weissman SM; Engelhard VH
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5056-60. PubMed ID: 6192447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.
    Gaston JS; Wallace LE; Rickinson AB; Epstein MA; Pious D
    Immunogenetics; 1984; 19(6):475-86. PubMed ID: 6329950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved and variable structures in HLA class I molecules: a review.
    Colombani J
    Tissue Antigens; 1990 Mar; 35(3):103-13. PubMed ID: 1695772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human histocompatibility antigen mutants immunoselected in vitro. Biochemical analysis of a mutant which synthesizes an altered HLA-A2 heavy chain.
    Krangel MS; Pious D; Strominger JL
    J Biol Chem; 1982 May; 257(9):5296-305. PubMed ID: 6978338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural identity between HLA-A2 antigens differentially recognized by alloreactive cytotoxic T lymphocytes.
    Castaño AR; Lauzurica P; Domenech N; López de Castro JA
    J Immunol; 1991 May; 146(9):2915-20. PubMed ID: 2016531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.